Your browser doesn't support javascript.
loading
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.
Rossing, Peter; Anker, Stefan D; Filippatos, Gerasimos; Pitt, Bertram; Ruilope, Luis M; Birkenfeld, Andreas L; McGill, Janet B; Rosas, Sylvia E; Joseph, Amer; Gebel, Martin; Roberts, Luke; Scheerer, Markus F; Bakris, George L; Agarwal, Rajiv.
Affiliation
  • Rossing P; Steno Diabetes Center Copenhagen, Herlev, Denmark.
  • Anker SD; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Filippatos G; Department of Cardiology (CVK) and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité-Universitätsmedizin, Berlin, Germany.
  • Pitt B; School of Medicine, National and Kapodistrian University of Athens, Department of Cardiology, Attikon University Hospital, Athens, Greece.
  • Ruilope LM; Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI.
  • Birkenfeld AL; Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research Imas12, Madrid, Spain.
  • McGill JB; CIBER-CV, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Rosas SE; Faculty of Sport Sciences, European University of Madrid, Madrid, Spain.
  • Joseph A; German Center for Diabetes Research (DZD), München-Neuherberg, Germany.
  • Gebel M; Department of Internal Medicine, Division of Diabetology, Endocrinology, and Nephrology, and Institute of Diabetes Research and Metabolic Diseases (IDM), Helmholtz Center Munich and University Hospital Tübingen, Tübingen, Germany.
  • Roberts L; Division of Endocrinology, Metabolism and Lipid Research, Washington University in St. Louis, St. Louis, MO.
  • Scheerer MF; Kidney and Hypertension Unit, Joslin Diabetes Center and Harvard Medical School, Boston, MA.
  • Bakris GL; Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA.
  • Agarwal R; Cardiology and Nephrology Clinical Development, Bayer AG, Berlin, Germany.
Diabetes Care ; 45(12): 2991-2998, 2022 12 01.
Article in En | MEDLINE | ID: mdl-35972218
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Diabetic Nephropathies / Renal Insufficiency, Chronic Type of study: Clinical_trials Limits: Humans Language: En Journal: Diabetes Care Year: 2022 Type: Article Affiliation country: Denmark
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Diabetic Nephropathies / Renal Insufficiency, Chronic Type of study: Clinical_trials Limits: Humans Language: En Journal: Diabetes Care Year: 2022 Type: Article Affiliation country: Denmark